Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

ROHTO Pharmaceutical raises operating profit thanks to strong Asia business

ROHTO Pharmaceutical reported an operating result of ¥7.5 billion for Q4, 4.1% above Jefferies’ forecasts but 8.9% below the ¥8.4 billion consensus. Consolidated revenue rose 9.6% and operating profit increased 8.1%, with an operating margin of 8.3% (down 0.1 percentage points). Strong brand performance and regional growth contributed: Hada Labo +14%, Melano CC +4.9%, Obagi +16.2%; Japan grew in the high single digits, China in the low single digits, Hong Kong in the mid single digits, Indonesia in the high double digits and Vietnam in the mid double digits. For fiscal 2027 the company forecasts revenue growth of 7.5%, operating profit growth of 6.5% and announces a dividend increase; a briefing is scheduled for Thursday. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, ROHTO PHARM. has already paid €0.14 in dividends. The last payout was in June.

Financials

In the last quarter, ROHTO PHARM. had revenue of €493.61M and net profit of €57.38M

(EUR)	June 2026	YoY
Revenue	493.61M	2.08%
Gross profit	275.02M	2.80%
Net profit	57.38M	17.36%
EBITDA	97.83M	14.85%

Fundamentals

Metric	Value
Market capitalization	€3.49B
Number of shares	225.96M
52-week high/low	€17.58 - €12.49
Dividend yield	1.63%
Dividends TTM	€0.25
Beta	-0.41
P/E ratio	18.69
PEG ratio	-6.10
P/B ratio	2.00
P/S ratio	1.75

Company profile

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.